Filing Details

Accession Number:
0000711377-10-000018
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-10-04 19:36:15
Reporting Period:
2010-10-01
Filing Date:
2010-10-04
Accepted Time:
2010-10-04 19:36:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-10-01 6,415 $6.75 819,812 No 4 M Direct
Common Stock Disposition 2010-10-01 6,415 $32.96 813,397 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options Common Stock Option (Right to buy) Disposition 2010-10-01 6,415 $0.00 6,415 $6.75
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
134,792 2013-10-10 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 194,320 Indirect See Note #1
Footnotes
  1. Shares held in trust for the benifit of Mr. Herbert's wife Judith Herbert
  2. The options were granted as NQ options on 10/10/03 and became exercisable 33% yearly thereafter.